Board of Directors
A seasoned and highly-experienced team
At Exubrion, our Board of Directors bring a broad range of experience across numerous therapeutic and business areas to our team.
Chairman of the Board
Mr. Immanuel Thangaraj
Essex Woodlands Health Ventures, Inc.
Dr. Rob Readnour
Mountain Group Partners
Dr. Mark Pykett
Chief Scientific Officer
Ms. Julia Stephanus
Chief Commercial Officer
Aratana Therapeutics, Inc.
Mr. Peter Selover
Chief Executive Officer
Synovetin OA™ delivers sustained OA pain relief.1
Synovetin OA™ provides targeted, non-systemic therapy.2
- Data on file, Exubrion Therapeutics.
- Donecker JM, Fox SM. Safety and effectiveness of Synovetin OA™: Results of three randomized trials evaluating treatment of naturally occurring canine elbow osteoarthritis. Exubrion Therapeutics, July 2019.